Recent Headlines
Within Health Care Products
Parvus Therapeutics Announces FDA Clearance of Investigational New Drug Application for PVT201
FDA Clearance of Investigational New Drug Application for PVT201, in development for the treatment of autoimmune liver disease and prevention of organ transplant rejection, is the first candidate from the Parvus nanomedicine immune tolerance platform to clear an IND. - October 19, 2026 - Parvus Therapeutics U.S., Inc.
Microvascular Therapeutics Selected to Present Investment Opportunity at ACQUICON 2026
Microvascular Therapeutics, Inc. (“MVT”), a clinical-stage biotechnology company developing next-generation ultrasound imaging and therapeutic technologies, today announced that it has been selected to present in the ACQUICON 2026 Deal Room on Tuesday, October 20, 2026, from 12:30–1:30 p.m. Mountain Time at the Karen Gail Miller Conference Center in Salt Lake City. - October 14, 2026 - Microvascular Therapeutics, Inc.
Advantage Healthcare Services Launches ACE, a Provider Education Initiative to Close Gaps in Behavioral Health Treatment Adherence
Advantage Healthcare Services announced the launch of ACE (Advantage Clinical Education™), a provider education initiative designed to help behavioral health care teams address treatment adherence challenges. The inaugural program explores strategies to reduce relapse risk, improve continuity of care, and support better outcomes for individuals living with bipolar disorder and schizophrenia through practical education and companion resources. - October 13, 2026 - Advantage Healthcare Services
NYX Health Launches AI-Powered Prior Authorization Solution to Streamline Healthcare Authorization Workflows
New solution combines AI-powered automation with the option for experienced prior authorization support, giving healthcare organizations greater flexibility in how they manage authorizations. NYX Health, a healthcare revenue cycle solutions company specializing in prior authorization services,... - October 12, 2026 - NYX Health
South West Logistics Completes Time-Critical 15-Room Healthcare Installation in Las Cruces
El Paso-based team mobilizes on short notice to deliver and install 30 pallets of medical equipment ahead of scheduled inspections. - October 11, 2026 - South West Logistics Inc.
AI Can Answer Your Questions. But Can It Truly Understand You? BYOU Brings Humans Back.
As millions turn to AI for emotional support, BYOU Wellbeing is bringing real human connection back. Its free Help Request feature allows people to anonymously share personal struggles and receive different perspectives from wellbeing professionals worldwide. From mental health and relationships to personal growth, BYOU challenges the idea that algorithms alone can replace human understanding, empathy and professional experience. - October 11, 2026 - BYOU Impact Foundation
Thandie Wellness Launches to Redefine Early Perimenopause for Millennial Women
A pharmacist-founded wellness brand introduces science-backed supplements and much-needed conversation around one of women's most overlooked life stages. Thandie Wellness, a pharmacist-founded wellness company headquartered in New York, NY, announced the launch of its inaugural line of supplements... - October 07, 2026 - Thandie Wellness
THROMBOLEX Announces Interim RAPID-PE Results
THROMBOLEX Announces Interim RAPID-PE Results Showing Favorable Safety and Reproducible Multicenter Results in Acute Pulmonary Embolism. Mechanically channeled thrombolysis procedure disrupts and dissolves thrombus in a single on-the-table session. - October 05, 2026 - Thrombolex, Inc.
Microvascular Therapeutics to Present Phase II CardiSon™ Data at 40th International Bubble Conference in Chicago
Next-generation ultrasound enhancing agent demonstrated improved left ventricular opacification and significantly reduced acoustic shadowing - October 02, 2026 - Microvascular Therapeutics, Inc.
SB 1088, Updating California’s Medical Decision-Making Tools, Signed by Governor Newsom
The Coalition for Compassionate Care of California (CCCC’s) Chief Executive Officer, Jennifer Moore Ballentine, MA, today announced that SB 1088, a bill to update and amend California’s laws governing do not resuscitate and portable medical orders, has been signed into law by Governor... - September 30, 2026 - Coalition for Compassionate Care
RxProtect and HealthBook+ Partner to Deliver Medication Savings and Personalized Care
Collaboration combines RxProtect's nurse-driven member support with HealthBook+'s clinician-led AI platform to better advocate for members taking high-cost medications. - September 30, 2026 - HealthBook+
South West Logistics Mobilizes on Short Notice to Prepare 24 Healthcare Rooms for Monday Opening
Southern California healthcare logistics team receives equipment for a 33-room project with less than a week's notice, adapts to changing site conditions and completes every installation-ready room before opening day. - September 20, 2026 - South West Logistics Inc.
SignaBlok Awarded NIH NIDDK Grant to Develop Novel TREM-1 Antagonist Drug for Inflammatory Bowel Disease
SignaBlok, Inc. has been awarded a Phase I SBIR grant from the NIH NIDDK to advance the development of a novel mechanism-based therapy for inflammatory bowel disease (IBD). The award supports SignaBlok's differentiated approach to targeting TREM-1 in IBD. - September 18, 2026 - SignaBlok, Inc.
Rob Merrill Named CEO of TFives, Life Sciences AI Compliance
TFives appoints 25-year healthcare regulatory veteran as CEO to lead enterprise adoption of compliance-ready AI governance for the Life Sciences industry. - September 17, 2026 - TFives
Microvascular Therapeutics Appoints George Kokke to Board of Directors
Veteran family office executive and healthcare investor brings more than 30 years of investment, finance, and board experience. - September 17, 2026 - Microvascular Therapeutics, Inc.
The Rare Cancer That Can Return Decades Later Brings Patients Together to Launch the Solitary Fibrous Tumor Foundation
The Solitary Fibrous Tumor Foundation (SFTF) today announced its launch as the first patient- and supporter-led nonprofit organization dedicated entirely to Solitary Fibrous Tumor (SFT), an ultra-rare sarcoma.The announcement comes during Sarcoma Awareness Month, observed globally each July. SFT... - September 17, 2026 - Solitary Fibrous Tumor Foundation
Endolumik Expands Gastrointestinal Calibration Tube Into Colorectal Surgery, Broadening Its FDA-Registered Platform
Endolumik, a medical device company developing fluorescence-guided surgical tools for minimally invasive procedures, today announced it has expanded the labeled use of its Endolumik Gastrointestinal Calibration Tube to include lower gastrointestinal tract surgical procedures, including colorectal... - September 14, 2026 - Endolumik, Inc.
Microvascular Therapeutics Appoints Charles Garrison, MD, to Scientific Advisory Board
Dr Charles Garrison, an experienced pathologist, biotechnology entrepreneur, and life sciences investor will advise MVT on scientific and medical development as new Scientific Advisory Board member. - September 14, 2026 - Microvascular Therapeutics, Inc.
MVT Nanobubbles Enable Non-Thermal Focused Ultrasound Ablation in Preclinical Brain Tumor Study
University of Utah researchers use MVT-101 phase-shift nanobubbles with focused ultrasound and MRI to confirm treatment location - September 14, 2026 - Microvascular Therapeutics, Inc.
South West Logistics Expands White-Glove Recovery Capabilities with Rapid Response in South Dakota
South West Logistics completed an urgent white-glove recovery in Rapid City, South Dakota, after the original delivery team was unable to place two large pharmaceutical refrigerators. SWL quickly coordinated local resources to complete the job, demonstrating its ability to solve difficult medical equipment and final-mile delivery challenges. - September 09, 2026 - South West Logistics Inc.
Kepon Biotech Addresses Global Biopharma Supply‑Chain Pain Points with China‑Based One‑Stop Procurement System
Kepon Biotech is a Chinese one‑stop supply‑chain partner for life‑science clients. It resolves procurement challenges: scattered suppliers, complex cross‑border compliance, variable batch quality and long lead‑times. It provides consolidated sourcing, special‑goods compliance, graded cold‑chain logistics and global certifications for cell lines, culture media, LAL reagents and clinical materials, delivering streamlined, low‑risk procurement for pharma, IVD, CRO/CDMO and research institutes. - September 07, 2026 - Shanghai Kepon Biotech Co., Ltd.
Asclepii Selected to Exhibit Poseidon at Vizient Innovative Technology Exchange
Asclepii will showcase its FDA 510(k)-cleared Poseidon™ Nanosilver Hydrogel at Vizient’s Innovative Technology Exchange in Las Vegas on September 24, marking an important milestone in the company’s commercial expansion and bringing its wound care technology to healthcare leaders across Vizient’s network. - September 04, 2026 - Asclepii
78% of Caregivers Report Burnout; SonderCare Highlights Equipment’s Role in Easing the Load
New research shows caregiver stress is persistent and widespread — SonderCare explains how thoughtfully designed home care equipment can reduce the physical burden that compounds daily exhaustion. - September 04, 2026 - SonderCare
SonderCare Addresses Home Care Equipment Gap as Families Choose Aging in Place
As Canada's New Brunswick province commits $4 million to expand its Nursing Home Without Walls program — and nursing home waitlists swell to nearly 1,000 patients — the conversation around aging in place has shifted from preference to urgent necessity. SonderCare, a premium home hospital bed manufacturer with over 25 years of healthcare expertise, says the policy momentum is meaningful, but its impact depends entirely on whether the right equipment is available inside the home. - September 04, 2026 - SonderCare
VMRD Launches Rapid Horse-Side Insulin Test to Decrease Risk of Laminitis in Metabolic Horses
VMRD, Inc. is thrilled to share the launch of their exciting new test for horse-side measurement of insulin in horses. Run on the same palm-sized reader as VMRD SAA and Foal IgG, this highly portable multi-functional testing platform embodies VMRD’s vision of improving animal health through... - August 28, 2026 - VMRD, Inc.
The Peptide App Opens Public COA Evidence Index with 5,225 Documents
The Peptide App launched a free public COA Evidence Index containing 5,225 documents, along with a label-first reconstitution calculator. The launch addresses a fast-changing online peptide market: 60 of 82 storefront domains with available registration dates in the app’s current vendor sample were registered in 2024 or later. The index helps people inspect testing records, sources, and limitations without treating a COA as proof of product quality or safety. - August 26, 2026 - The Peptide App
Luminex Wellness & Aesthetics Expands Concierge Perimenopause & Menopause Care with Personalized Hormone Evaluations - Initial Consultation May be Covered by Insurance
New approach focuses on treating women—not just lab results—while helping address common symptoms of perimenopause and menopause. - August 24, 2026 - Luminex Wellness & Aesthetics
Gallion Health Announces Yale New Haven Health as Development Partner and Investor to Advance Next-Generation Supply Chain Technology
Joint Development Partnership provides Gallion Health access to one of the country’s leading academic health systems to further the development of the Company’s products and service offerings. - August 19, 2026 - Gallion Health, Inc.
Kepon Biotech Launches Integrated Cross‑Border Risk‑Control Solutions for Global Cell Culture Media Trade
Kepon Biotech handles import‑export for fermentation, research and GMP clinical‑grade cell culture media. It addresses cross‑border risks such as bioactivity degradation, complex global regulations and customs detention. With EAC, REACH, FDA, TGA, PMDA, CMDCAS and Halal credentials, it delivers grade classification, global certification, light‑shielded cold‑chain logistics and multilingual customs documents for global CDMOs, biomanufacturers and research labs. - August 19, 2026 - Shanghai Kepon Biotech Co., Ltd.
Kepon Biotech Launches Integrated Cross‑Border Solutions for Global Spermidine Procurement
Kepon Biotech provides multi‑grade spermidine and spermidine trihydrochloride for food, pharma, cosmetics and life‑science research. It mitigates cross‑border risks such as oxidative degradation, complex certification rules and HS misclassification. Backed by EAC, REACH, FDA and Halal credentials, it delivers one‑stop certification, nitrogen‑sealed temperature‑controlled logistics and multilingual customs documents for manufacturers, labs and distributors across EAEU, EU, U.S. and Middle‑East. - August 19, 2026 - Shanghai Kepon Biotech Co., Ltd.
Kepon Biotech Launches One-Stop Cross-Border Compliance & Logistics Solutions for Life Science Reagents
Kepon Biotech provides a one-stop global compliance and supply system for life science procurement. It solves core cross-border challenges including complex customs clearance, unstable cold-chain logistics, fragmented regional regulations. The company offers standardized biochemical reagents, reference standards and cell culture media, with full compliance support and segmented temperature-controlled logistics, delivering reliable, low-risk sourcing for global labs and pharmaceutical manufacture - August 19, 2026 - Shanghai Kepon Biotech Co., Ltd.
Health Roads Files Ten Provisional Patent Applications Across Medicaid Revenue Cycle, Interoperability, Program Enrollment, and Social Health Information Exchange
Company-held portfolio spans SocialRCM®, QConnect™, and NextCareEngage™ product lines and its social health information exchange infrastructure; first filing enters production this year. - August 18, 2026 - Health Roads, LLC
Kepon Biotech Launches Integrated Cross‑Border Export Solutions for Global LAL Endotoxin‑Testing Reagent Procurement
Kepon Biotech delivers factory‑sourced LAL endotoxin‑testing kits for biopharma, vaccine and medical‑device clients. Working with ISO13485‑certified manufacturers, it provides regional compliance paperwork, 2‑8°C cold‑chain logistics and low‑MOQ trial orders across CIS, Southeast Asia, Middle East, EU and North America. Its one‑stop export solution fixes customs detention, reagent deactivation and raw‑material stock‑out risks for 1000+ users in 50+ countries. - August 18, 2026 - Shanghai Kepon Biotech Co., Ltd.
Kepon Biotech Unveils Full-Link Risk Control & Compliance Solutions for Global Cell Culture Media Trade
Global labs and biopharma firms encounter common cell culture media procurement risks: inconsistent batches, customs delays, cold chain product inactivation and inflexible high MOQs. Shanghai Kepon Biotech releases a full cross-border supply solution and procurement risk guide, offering flexible samples, one-stop biological goods clearance and segmented cryogenic logistics for global cell research, biotech and diagnostic manufacturers. - August 18, 2026 - Shanghai Kepon Biotech Co., Ltd.
Kepon Biotech Launches Comprehensive Cross-Border Procurement & Risk Control Solutions for Industrial Fine Chemicals
Global factories, energy plants and research labs run into widespread procurement risks for industrial chemicals: inconsistent purity, hazardous goods customs blockages, failed long-distance shipping, rigid high MOQs and incomplete compliance documents. Shanghai Kepon Biotech releases an integrated cross-border supply system and complete pitfall guide, providing flexible trial orders, one-stop chemical customs agency and dedicated hazardous cold chain logistics for biotech, pharmaceutical. - August 17, 2026 - Shanghai Kepon Biotech Co., Ltd.
Kepon Biotech Launches Integrated Cross-Border Procurement and Risk Control Solutions for High-Purity Organic & Inorganic Chemicals
Global labs and pharma face organic & inorganic chemical procurement risks including unstable purity, customs detention, failed shipping, high MOQs and incomplete SDS docs. Shanghai Kepon Biotech releases a cross-border supply & risk guide with flexible samples, full chemical clearance and custom cold chain logistics for life science and new energy industries. - August 17, 2026 - Shanghai Kepon Biotech Co., Ltd.
Shanghai Kepon Biotech Launches Full Risk-Control Cross-Border Solutions for Certified Reference Standards Procurement
Global labs, pharma and food testers face China reference standards cross-border risks: poor batch traceability, customs delays, rigid MOQs, cold chain breakdowns and missing COA/SDS. Shanghai Kepon Biotech offers integrated supply, special goods clearance and segmented cold chain for life science, new energy and food testing industries. - August 17, 2026 - Shanghai Kepon Biotech Co., Ltd.
Food Safety Standards Raw Material Procurement Solutions & Risk Avoidance Guide Released by Shanghai Kepon Biotech for Global Food Testing & Food Manufacturing Plants
Global food manufacturers and third-party food testing labs face severe procurement risks for food safety reference standards: inconsistent batch purity, cross-border food regulatory document gaps, strict customs inspection, high MOQ limits and incomplete compliance certification. Shanghai Kepon Biotech launches integrated cross-border supply system, one-stop food safety filing and traceable certified standards for food testing, beverage and food processing industries worldwide. - August 16, 2026 - Shanghai Kepon Biotech Co., Ltd.
GenRocket Launches Proof of Value Program to Accelerate Enterprise Adoption of AI-Powered Unstructured Data Privacy
Fixed-price evaluation enables organizations to validate AI-assisted document redaction while reducing adoption risk and accelerating privacy-safe testing and AI initiatives. - August 13, 2026 - GenRocket, Inc.
AaNeel Meets CMS Kill the Clipboard Pledge with the Health Access Card®
Health Access Card® workflow gives patients greater control of their health information while enabling secure provider access at the point of care. - August 13, 2026 - AaNeel
New 2026 Report Reveals an AI/LLM Gap Between Biopharma Sponsors and Their CROs/Vendors
Life Science Strategy Group looks beyond frontier-AI hype to show how biopharma teams use AI and LLMs in daily work, and where their CRO and vendor partners are falling short. 71% of sponsors rate their own AI/LLM output highly. Only 27% say the same of their CROs and vendors. - August 12, 2026 - Life Science Strategy Group, LLC
Ferrari and Dr. David Pincus of Pincus Plastic Surgery Unveil a Luxury Lounge Experience at the Hamptons Concours
The roar of rare Ferraris, the unmistakable elegance of the Hamptons, and one of plastic surgery's most recognizable luxury brands came together for an unforgettable weekend at the 2026 Hamptons Concours, produced by luxury event visionary Bradford Rand. Widely regarded as one of the East Coast's... - August 10, 2026 - Pincus Plastic Surgery
Plastic Surgeon Dr. David Pincus Sponsors the Hamptons Concours d’Elegance Supporting the Southampton Animal Shelter Foundation
Plastic Surgeon Dr. David Pincus and Pincus Plastic Surgery proudly sponsored the 2026 Hamptons Concours d'Elegance, one of the Hamptons' premier luxury charity events, bringing together exotic automobiles, luxury brands, community leaders, and philanthropists for a day dedicated to supporting the... - August 06, 2026 - Pincus Plastic Surgery
Vertis Health Appoints Hollie Hastings as Head of Partnerships and Integration
Vertis Health is pleased to announce the appointment of Hollie Hastings as Head of Partnerships and Integration. Hollie’s appointment marks an important step in Vertis’s commitment to providing effective and reliable services across Worcestershire, with her role focusing on the new Neighbourhood Health programme. - August 06, 2026 - Vertis Health
Lobbie Continues Building the Modern Clinic Platform with Enhanced Patient Billing
Today’s clinics can strengthen cash flow and streamline operations building more sustainable businesses by unifying patient acquisition, intake, clinical workflows, billing, memberships, and payments in one integrated platform. - August 06, 2026 - Lobbie
Minus K Technology Launches It Educational Giveaway for Universities and Colleges in the USA
Minus K Technology announces its 11th Educational Giveaway of passive mechanical vibration isolators for Universities and Colleges within the USA. Winners get a free brand new negative-stiffness vibration isolator to be used at their school. - August 03, 2026 - Minus K Technology Inc.
OneShare Health Announces Expanded Maternity and Preventive Sharing for Complete and Classic Programs
OneShare Health, a Christian Health Care Sharing Ministry, today announced expanded Maternity and Preventive Sharing Limits for its Complete and Classic Programs, effective August 1, 2026. - July 31, 2026 - OneShare Health
EmergentMedTech Earns Five Nominations at the 2026 Aesthetic Awards
Partner practices, a proprietary treatment technique, and the company's plasma and regenerative technologies are recognized across five categories. - July 30, 2026 - EmergentMedTech
How WVU Medicine Increased Clinical Appeal Capacity 5X and Defended $16 Million in Revenue
As denial volumes continue to rise nationwide, WVU Medicine is redefining clinical appeals through AI-Enhanced Clinical Appeals™. By partnering with The Wellington Group and implementing AppealNavigator™, the health system defended $16 million in revenue, increased clinical appeal capacity 5X, and dramatically improved the quality, consistency, and speed of appeals—all while empowering its own clinical experts to outperform national benchmarks. - July 28, 2026 - The Wellington Group, LLC
Microvascular Therapeutics Highlights the Future of Ultrasound Theranostics in Comprehensive Wiley Review
Microvascular Therapeutics, Inc. (MVT) today announced publication of a comprehensive review in Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (WIREs Nanomedicine and Nanobiotechnology), a leading peer-reviewed journal with a 2025 Journal Impact Factor of 8.6, entitled,... - July 28, 2026 - Microvascular Therapeutics, Inc.